CD8A and neoplasm: In melanoma mice treated with anti-PD-1/PD-L1 drugs, the genus Bifidobacterium was discovered to be the main inducer for enhanced tumor-specific T cell responses and intratumoral CD8+ T cells (Shui et al., 2020; Liu et al., 2021).